Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy

Area of Science:

• Hematology
• Oncology
• Leukemia Research

Background:

• Mixed-phenotype acute leukemia (MPAL) presents significant diagnostic and therapeutic challenges.
• Patients with MPAL often experience poor prognoses.
• Uncertainty regarding optimal treatment strategies stems from classification difficulties, limited prospective data, and rare incidence.

Purpose of the Study:

• To review recent findings and summarize the current understanding of Mixed-phenotype acute leukemia.
• To highlight diagnostic and therapeutic challenges associated with MPAL.
• To discuss the implications of recent genetic discoveries for future MPAL classification and treatment.

Main Methods:

• Review of recent cytogenetic and genetic sequencing studies in MPAL.
• Analysis of available data on therapeutic outcomes comparing different induction regimens.
• Evaluation of the role of allogeneic transplantation versus chemotherapy in first remission.

Main Results:

• Most MPAL cases exhibit cytogenetic abnormalities and frequent mutations in epigenetic regulators, tumor suppressors, and transcription factors.
• Acute lymphoblastic leukemia-like induction regimens appear more effective than acute myeloid leukemia-type approaches.
• Allogeneic transplantation in first remission may offer improved survival compared to consolidation chemotherapy.

Conclusions:

• Understanding the genetic landscape of MPAL is crucial for developing biologically driven classifications and personalized therapies.
• Current therapeutic data are largely based on retrospective studies.
• Prospective trials incorporating targeted approaches based on genetics and immunophenotype are essential for advancing MPAL treatment.